Rising Chronic Diseases Driving India Pharmaceuticals Market at an Anticipated CAGR of 11.62% During 2025-30

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

India Pharmaceuticals Market Overview, Trends, Size and Forecast: 2025-2030

The India Pharmaceuticals Market size was valued at around USD 53.29 billion in 2024 and is projected to reach USD 92.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.62% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The market growth is driven by several factors, including the growing cases of chronic disorders such as diabetes, cardiovascular diseases, kidney disorders, & many more, the encouragement by the Indian government, and the acceptance of green synthesis of drugs by using renewable energy. One of the major growth factors is the high demand for Indian pharmaceuticals in the global markets, which is creating ample growth opportunities for the market players. Indian pharmaceutical products are cost-effective and approved by international regulators like the WHO and the USFDA, thus highly preferred by foreign markets, like the US, Europe, etc.

Additionally, the national government is promoting the Indian pharmaceutical industry by implementing various policies, such as the Pharma Vision 2020, PLI scheme, etc., and significantly investing in the development of this industry. Also, the growing trade agreements between India and other countries are potentially increasing the market growth, as these relations allow the Indian Pharmaceutical Markets to enter with low & no-cost tariffs & negligible taxes in foreign markets.

Moreover, the rapid acceptance of sustainable practices in the synthesis of various drugs and the active ingredients to reduce pollution and to protect environmental & human health due to growing environmental concerns is positively shaping this market. However, the companies producing generic pharmaceutical products are highly competing with other innovator companies that are producing actual innovative drugs are hindering the market growth & expansion, further states the research report, “India Pharmaceuticals Market Analysis, 2025.”

India Pharmaceuticals Market Segmentation Insights:

Prescription Drugs Witness Massive Market Demand

Based on the product type, the market is further segmented into prescription drugs, over-the-counter drugs, and biologics & biosimilars. Among these, the prescription drugs are leading the market and hold the largest market share of around 70%. These are dominating due to the high burden of chronic diseases in India, which requires the recommendation of doctors for better prevention and cure. Additionally, customers have trust in prescription drugs because these are recommended by doctors, thus contributing to market growth. Also, these drugs have widespread adoption and usage for a variety of diseases like diabetes, respiratory diseases, tuberculosis, cardiovascular diseases, and many more, thus creating a high demand in the market.

Moreover, prescription drugs are highly affordable and easily available over other types of drugs, including biologics, biosimilars, and over-the-counter medicines. Consequently, billions of units of prescription drugs are produced in India per year, showing their dominance in the India Pharmaceutical Market. 

Hospital Pharmacies Serving a Large Group of Customers

Hospital pharmacies hold the largest market share of about 26%. The dominance is due to the widespread presence of hospital pharmacies across India, which is more than 40,000 in number. These are rapidly growing as hospitals deal with a large number of patients daily, which increases the probability of these patients purchasing medications from the nearest spot, which is the hospital pharmacy itself, thus contributing to the dominance of these in the market. Additionally, the majority of the medications are prescription drugs only, which are only written in hospitals during visits, so it makes it easier for the patients to purchase the drugs from the nearest distribution channel, that is, the hospital pharmacies, thus generating maximum market demand from this distribution channel.

Moreover, hospital pharmacies are equipped with healthcare services such as diagnostics and treatment, making them convenient for patients to get prescribed medicines quickly, improving treatment adherence. All these factors are making hospital pharmacies the most preferred distribution channel in the industry.

Top Companies in the India Pharmaceuticals Market

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading India Pharmaceuticals Market companies, including Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Biocon Ltd., and Others are looking forward to increase their market size & share.

Key Questions Answered in the Research Report

1. What is the scope, size, value, and forecast of the India Pharmaceuticals Market?
2. What is the volume and share of each segment in the India Pharmaceuticals Market?
3. What are the key trends shaping the India Pharmaceuticals Market from 2025 to 2030?
4. What growth factors and risks impact the India Pharmaceuticals Market?
5. What are the main challenges faced by players in the India Pharmaceuticals Market?
6. What are the top opportunities in the India Pharmaceuticals Market?
7. What does competitive analysis reveal about the India Pharmaceuticals Market landscape?
8. Who are the key players and companies leading the India Pharmaceuticals Market?
9. What innovations are transforming the future dynamics of the India Pharmaceuticals Market?
10. How are partnerships and collaborations driving the India Pharmaceuticals Market growth?
11. How does the India Pharmaceuticals Market differ based on geography and segments?